By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


RXi Pharmaceuticals 

1500 West Park Drive
Suite 210
Westborough  Massachusetts  01581  U.S.A.
Phone: 508-767-3861 Fax: 508-767-3862


Company News
RXi Pharmaceuticals (RXII) Announces Closing Of The Exclusive Global Licensing Agreement To Samcyprone™ With Hapten Pharmaceuticals 2/5/2015 8:34:15 AM
RXi Pharmaceuticals (RXII) Strengthens Intellectual Property Portfolio For Ocular Indications 2/3/2015 10:56:50 AM
RXi Pharmaceuticals (RXII) To Present At The 17th Annual Biotechnology Industry Organization (BIO) CEO & Investor Conference 2/2/2015 11:44:29 AM
RXi Pharmaceuticals (RXII) To Present At The 7th Annual Biotech Showcase™ 1/5/2015 8:17:48 AM
RXi Pharmaceuticals (RXII) Issues Open Letter To Shareholders 12/22/2014 9:05:53 AM
RXi Pharmaceuticals (RXII) Expands Its Clinical Pipeline With An Exclusive Global License For A Second Phase 2 Clinical Compound 12/19/2014 7:47:00 AM
RXi Pharmaceuticals (RXII) Announces Sustained Effect Of RXI-109 At Three Months Post Scar Revision Surgery And The Completion Of Enrollment For Its Phase 2a Trial RXI-109-1301 12/17/2014 8:02:58 AM
RXi Pharmaceuticals (RXII) Reports Financial Results For The Third Quarter Of 2014 11/13/2014 7:55:33 AM
RXi Pharmaceuticals (RXII) To Present New Data In Its First Phase 2a Clinical Trial With RXI-109 10/7/2014 7:45:00 AM
RXi Pharmaceuticals (RXII) To Present At The 13th Annual Biotechnology Industry Organization (BIO) Investor Forum 9/29/2014 10:01:22 AM